References
Berova N, Petkov I, Andreev V (1974) Treatment of chronic urticaria with a proteinase (kallikrein) inhibitor. Br J Dermatol 90:431–434
Czarnetzki BM (1986) Mediators, In: Czarnetzki BM (ed) Urticaria. Springer-Verlag, Berlin Heidelberg New York Tokyo pp 13–24
Doeglas H, Bleumink E (1975) Protease inhibitors in plasma of patients with chronic urticaria. Arch Dermatol 111:979–985
Dor PJ, Vervloet D, Sapene M, Andrac L, Bonerandi JJ, Charpin J (1983) Induction of late cutaneous reaction by kallikrein injection: comparison with allergic-like late response to compounds 48/80. J Allergy Clin Immunol 71:363–370
Hägermark Ö (1974) Studies on experimental itch induced by kallikrein and bradykinin. Acta Derm Venereol (Stockh) 54:397–400
Juhlin L (1981) Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 104:369–381
Juhlin L, Michaëlsson G (1969) Cutaneous reactions to kallikrein, bradykinin and histamine in healthy subjects and in patients with urticaria. Acta Derm Venereol (Stockh) 49:26–36
Juhlin L, Michaëlsson G (1969) Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema. Acta Derm Venereol (Stockh) 49:37–44
Michaëlsson G (1969) Chronic urticaria. A clinical study with special reference to vascular reactions mediated by the kallikrein-kinin system. Acta Derm Venereol (Stockh) 49:404–416
Schachter M (1969) Kallikreins and kinins. Physiol Rev 49:510–523
Werle E (1967) Plasmakinine. Dtsch Med Wochenschr 92:1573–1580
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Imai, S. Cutaneous reactions to kallikrein and histamine in patients with urticaria. Arch Dermatol Res 281, 437–439 (1989). https://doi.org/10.1007/BF00455332
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00455332